State Street’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$136M Buy
5,699,265
+470,736
+9% +$13.1M ﹤0.01% 1192
2025
Q4
$145M Buy
5,228,529
+1,219,871
+30% +$31.1M ﹤0.01% 1140
2025
Q3
$97.3M Buy
4,008,658
+370,392
+10% +$7.37M ﹤0.01% 1348
2025
Q2
$61.9M Buy
3,638,266
+198,147
+6% +$3.45M ﹤0.01% 1572
2025
Q1
$67.2M Buy
3,440,119
+362,742
+12% +$9.5M ﹤0.01% 1495
2024
Q4
$76.3M Sell
3,077,377
-852,180
-22% -$21.7M ﹤0.01% 1508
2024
Q3
$96.3M Buy
3,929,557
+437,402
+13% +$11.3M ﹤0.01% 1347
2024
Q2
$81.8M Sell
3,492,155
-239,037
-6% -$5.87M ﹤0.01% 1387
2024
Q1
$123M Sell
3,731,192
-885,166
-19% -$27.6M 0.01% 1173
2023
Q4
$126M Buy
4,616,358
+474,229
+11% +$11.8M 0.01% 1149
2023
Q3
$99.6M Buy
4,142,129
+555,125
+15% +$14.9M 0.01% 1188
2023
Q2
$115M Buy
3,587,004
+350,916
+11% +$11.4M 0.01% 1126
2023
Q1
$99.1M Buy
3,236,088
+142,177
+5% +$5.61M 0.01% 1193
2022
Q4
$121M Buy
3,093,911
+531,502
+21% +$23.8M 0.01% 1057
2022
Q3
$122M Sell
2,562,409
-773,918
-23% -$44.1M 0.01% 996
2022
Q2
$129M Buy
3,336,327
+1,354,781
+68% +$53.9M 0.01% 999
2022
Q1
$114M Buy
1,981,546
+298,383
+18% +$19.6M 0.01% 1204
2021
Q4
$134M Buy
1,683,163
+281,443
+20% +$24.1M 0.01% 1082
2021
Q3
$122M Buy
1,401,720
+81,345
+6% +$8.17M 0.01% 1113
2021
Q2
$170M Buy
1,320,375
+102,104
+8% +$8.14M 0.01% 936
2021
Q1
$97.5M Sell
1,218,271
-212,139
-15% -$20.2M 0.01% 1253
2020
Q4
$117M Buy
1,430,410
+898,932
+169% +$44.2M 0.01% 1035
2020
Q3
$13.1M Buy
531,478
+308,179
+138% +$7.65M ﹤0.01% 2293
2020
Q2
$6.25M Buy
223,299
+33,918
+18% +$731K ﹤0.01% 2652
2020
Q1
$3.41M Buy
+189,381
New +$4.12M ﹤0.01% 2813

Other funds holding BEAM